Ad Header

PharmaLive

Slogan

The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

Bernie Sanders puts focus on healthcare with Medicare for All bill

U.S. Senator Bernie Sanders unveiled the latest version of his ambitious “Medicare-for-All” plan, moving the healthcare debate among Democratic presidential contenders to center stage in the 2020 race.

Read More »

Democrats welcome fight as Trump tees up 2020 healthcare battle

Democrats embraced U.S. President Donald Trump’s call to revive a fight over healthcare coverage, ensuring a prominent role for the issue in the 2020 election as Trump seeks a second term in office.

Read More »

Trump wants to work with Democrats on drug prices, infrastructure: aide

U.S. President Donald Trump is willing to work with congressional Democrats to lower drug prices for Americans and on infrastructure funding, White House adviser Kellyanne Conway said.

Read More »

U.S. House Democrats introduce sweeping ‘Medicare for All’ bill

Democrats in the U.S. House of Representatives unveiled an ambitious proposal to move all Americans into the government’s Medicare health insurance program.

Read More »

Sanofi and Regeneron cutting list price of cholesterol drug by 60 percent

Sanofi SA and Regeneron Pharmaceuticals Inc. will slash the U.S. list price of the companies’ potent but expensive cholesterol fighter Praluent by 60 percent.

Read More »

J&J to add prices to television ads

Johnson & Johnson will start adding the price of the company’s medicines to television commercials by March 2019, becoming the first drugmaker to heed a call by U.S. President Donald Trump.

Read More »

Powerful Senate committee invites pharma executives to testify

A powerful U.S. Senate committee invited seven pharmaceutical companies to testify at a hearing during February 2019 examining rising prescription drug prices.

Read More »

U.S. lawmakers request info from insulin makers on rising prices

Two powerful U.S. lawmakers sent letters to the three leading insulin manufacturers requesting information on why its cost has skyrocketed in recent years and how much the companies profit from the life-sustaining diabetes treatment.

Read More »

Senate Finance Committee and House Oversight Committee Take Aim at Drug Pricing

The U.S. Senate Finance Committee and the House Oversight Committee started hearings focused on high drug prices.

Read More »

U.S. insulin costs per patient nearly doubled from 2012 to 2016: study

The cost of insulin for treating type 1 diabetes in the United States nearly doubled over a five-year period, underscoring a national outcry over rising drug prices, according to a new analysis shared with Reuters.

Read More »

Ad Right Top

MedAdNews

Extensive pharmaceutical business and marketing intelligence. For back issues, please contact MDAD@kmpsgroup.com.

February 2019 Focus: Agenda 2019, Top 10 Pipelines To Watch, Value Of Pharmaceuticals, and more!

Subscribe

Ad Right Bottom